UCP-2 promoter polymorphism (-866G/A) affects its expression in beta cells and modulates clinical profiles of Japanese Type 2 diabetic patients.

被引：0
|
作者：
Sasahara, M [1 ]
Nishi, M [1 ]
Furuta, H [1 ]
Matsumoto, E [1 ]
Sasaki, H [1 ]
Nanjo, K [1 ]
机构：
[1] Wakayama Univ Med Sci, Dept Med 1, Wakayama, Japan
来源：
DIABETOLOGIA | 2003年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
377
引用
收藏
页码：A133 / A133
页数：1
相关论文
共 50 条
  • [31] CCR5 gene promoter polymorphism (59029A/G) associated with nephropathy in type 2 diabetic patients
    Tanaka, Y
    Mokubo, A
    Nakajima, K
    Watada, H
    Hirose, T
    Kawamori, R
    DIABETES, 2005, 54 : A199 - A199
  • [32] No association between adiponectin gene polymorphism (G276T) and incipient diabetic nephropathy in Japanese type 2 diabetic patients
    Yoshioka, K
    Yoshida, T
    Umekawa, T
    Toda, H
    Takakura, Y
    Kogure, A
    Yoshikawa, T
    DIABETES, 2004, 53 : A507 - A507
  • [33] Expression of DPP-4 in beta cells of type 2 diabetic subjects and the effects of its inhibition
    Buglianil, M.
    Masin, M.
    Paula, F. M. M.
    Omar, B. A.
    Mossuto, S.
    Suleiman, M.
    Grano, F.
    Boggi, U.
    Filipponi, F.
    Marselli, L.
    Ahren, B.
    Eizirik, D. L.
    Marchetti, P.
    DIABETOLOGIA, 2016, 59 : S74 - S74
  • [34] -250G/A LIPC POLYMORPHISM AND ITS RELATIONSHIP WITH PERIPHERAL ARTERY DISEASE IN TYPE 2 DIABETIC PATIENTS
    Jose Ariza, Maria
    Valdivielso, Pedro
    Rioja, Jose
    Alonso, Inmaculada
    de la Vega-Roman, Cristobal
    Gonzalez-Alegre, Teresa
    Angel Sanchez-Chaparro, Miguel
    Gonzalez-Santos, Pedro
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2008, 20 (01): : 22 - 27
  • [35] Interaction between the UCP2-866 G>A polymorphism, diabetes, and [beta]-blocker use among patients with acute coronary syndromes (vol 20, pg 231, 2010)
    Beitelshees, Amber L.
    Finck, Brian N.
    Leone, Teresa C.
    Cresci, Sharon
    Wu, Jun
    Province, Michael A.
    Fabbrini, Elisa
    Kirk, Erik
    Zineh, Issam
    Klein, Samuel
    Spertus, John A.
    Kelly, Daniel P.
    PHARMACOGENETICS AND GENOMICS, 2012, 22 (05): : 396 - 396
  • [36] Prevalence of-132(G/A) mutation in the IAPP promoter gene in type 2 diabetic patients and clinical features of the carriers
    Chico, A
    Rojas, I
    Julià, M
    Gomis, R
    Novials, A
    DIABETOLOGIA, 2004, 47 : A189 - A189
  • [37] Association of GCK Gene Promoter Polymorphism and their Role in its MRNA Expression among Type 2 Diabetes Mellitus Patients
    Fatima, Waseem
    Khan, Farah
    Ali, Ashraf
    Verma, Amit Kumar
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2020, 14 (10)
  • [38] Association of the-250G/A promoter polymorphism of the hepatic lipase gene with the risk of peripheral arterial disease in type 2 diabetic patients
    Valdivielso, Pedro
    Ariza, Maria Jose
    de la Vega-Roman, Cristobal
    Gonzalez-Alegre, Teresa
    Rioja, Jose
    Ulzurrun, Eugenia
    Gonzalez-Santos, Pedro
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2008, 22 (04) : 273 - 277
  • [39] UCP1-3826 A>G polymorphism affects weight, fat mass, and risk of type 2 diabetes mellitus in grade III obese patients
    Nicoletti, Carolina Ferreira
    Rus Perez de Oliveira, Ana Paula
    Franco Brochado, Maria Jose
    de Oliveira, Bruno Parenti
    de Souza Pinhel, Marcela Augusta
    Marchini, Julio Sergio
    dos Santos, Jose Ernesto
    Salgado Junior, Wilson
    Silva Junior, Wilson Araujo
    Nonino, Carla Barbosa
    NUTRITION, 2016, 32 (01) : 83 - 87
  • [40] Polymorphism in resistin promoter region at-420 determines the serum resistin levels and may be a risk marker of stroke in Japanese type 2 diabetic patients
    Tsukahara, Takayoshi
    Nakashima, Eitaro
    Watarai, Atsuko
    Hamada, Yoji
    Naruse, Keiko
    Kamiya, Hideki
    Nakamura, Nobuhisa
    Kato, Norihiro
    Hamajima, Nobuyuki
    Sekido, Yoshitaka
    Niwa, Toshimitsu
    Tomita, Makoto
    Oiso, Yutaka
    Nakamura, Jiro
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 84 (02) : 179 - 186
12345